HOUSTON (AP) _ Bellicum Pharmacueticals Inc. (BLCM) on Thursday reported fourth-quarter net income of $2.5 million.The Houston-based company said it had profit of 11 cents per share. Losses, adjusted for non-recurring gains, came to 27 cents per share.The drug developer posted revenue of $500,000 in the period.For the year, the company reported that its loss widened to $9.7 million, or 84 cents per share. Revenue was reported as $6.2 million.In the final minutes of trading on Thursday, the companyâ€™s shares hit $2.01. A year ago, they were trading at $3.67._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BLCM at https://www.zacks.com/ap/BLCM